✦ LIBER ✦

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma : The experience of the Gruppo Italiano Studio Linfomi

✍ Scribed by Paolo G. Gobbi; Chiara Broglia; Francesco Merli; Matteo Dell'Olio; Caterina Stelitano; Emilio Iannitto; Massimo Federico; Raffaella Bertè; Dimitri Luisi; Stefano Molica; Carla Cavalli; Laura Dezza; Edoardo Ascari

Book ID: 102106216
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 110 KB
Volume: 98
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11807

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab plus HyperCVAD alternating wit

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

✍ Francesco Merli; Stefano Luminari; Fiorella Ilariucci; Mario Petrini; Carlo Visc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Single-dose palonosetron for prevention

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

✍ Nicola Di Renzo; Antonella Montanini; Donato Mannina; Alessandra Dondi; Stefania 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

Early chemotherapy intensification with

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

✍ Andrea Gallamini; Caterina Patti; Simonetta Viviani; Andrea Rossi; Francesca Fio 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views